adenovirus-36
Showing 1 - 25 of 3,619
Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in
Recruiting
- Malignant Pleural Mesothelioma, Advanced
- Oncolytic Adenovirus H101
- Programmed death receptor-1 inhibitor
-
Tianjin, Tianjin, ChinaTianjin Medical Unversity Second Hospital
Sep 2, 2023
Refractory Angina Pectoris, Gene Transfer, Coronary Artery Disease Trial in Copenhagen, Kuopio (AdvVEGF-D, Control Rx)
Recruiting
- Refractory Angina Pectoris
- +2 more
- AdvVEGF-D
- Control Rx
-
Copenhagen, Denmark
- +1 more
Oct 19, 2022
Ebola Virus Trial in Kampala (cAd3-EBO S vaccine)
Completed
- Ebola Virus
- cAd3-EBO S vaccine
-
Kampala, UgandaMakerere University-Walter Reed Project
Nov 10, 2022
Metastatic Melanoma Trial in Copenhagen, Nantes (TILT-123)
Recruiting
- Metastatic Melanoma
- TILT-123
-
Copenhagen, Denmark
- +1 more
Dec 17, 2021
Cytomegalovirus, Adenovirus Trial in Memphis (VST infusion, CliniMACS)
Not yet recruiting
- Cytomegalovirus
- Adenovirus
- VST infusion
- CliniMACS
-
Memphis, TennesseeSt . Jude Children's Research Hospital
Jan 9, 2023
Marburg Virus Disease Trial in Silver Spring (cAd3-Marburg vaccine)
Completed
- Marburg Virus Disease
- cAd3-Marburg vaccine
-
Silver Spring, MarylandWRAIR Clinical Trials Center,
Aug 9, 2022
Colonic Tumors, Colorectal Tumors Trial in Detroit, New York, Cincinnati (GRT-C901, GRT-R902, Atezolizumab)
Recruiting
- Colonic Neoplasms
- Colorectal Neoplasms
- GRT-C901
- +4 more
-
Detroit, Michigan
- +2 more
Aug 1, 2022
Viral Infection After HSCT Trial (Virus -specific T cells)
Not yet recruiting
- Viral Infection After HSCT
- Virus -specific T cells
- (no location specified)
Mar 28, 2022
Abu Dhabi Diabetes and Obesity Study
Completed
- Obesity
- Diabetes
-
Abu Dhabi, United Arab EmiratesImperial College London Diabetes Centre
Oct 5, 2021
Viral Infection Trial in Washington, Houston (CMV/AdV /EBV/BKV specific T cells)
Recruiting
- Viral Infection
- CMV/AdV /EBV/BKV specific T cells
-
Washington, District of Columbia
- +1 more
Aug 6, 2021
Human Immunodeficiency Virus Trial in Boston (Ad26.Mos4.HIV, MVA-Mosaic, Clade C gp140 + Mosaic gp140)
Completed
- Human Immunodeficiency Virus
- Ad26.Mos4.HIV
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Feb 7, 2022
Respiratory Syncytial Virus Trial in Worldwide (Ad26.RSV.preF, Placebo, Nimenrix)
Completed
- Respiratory Syncytial Virus
- Ad26.RSV.preF
- +2 more
-
Geelong, Australia
- +24 more
Nov 23, 2021
Brain Cancer, Brain Tumor, Glioma Trial in Canada, United States (DNX-2401, pembrolizumab)
Completed
- Brain Cancer
- +10 more
- DNX-2401
- pembrolizumab
-
Little Rock, Arkansas
- +14 more
Jul 13, 2021
Hemophilia B Trial in Beijing (Sodium valproate extended-release tablets)
Recruiting
- Hemophilia B
- Sodium valproate extended-release tablets
-
Beijing, ChinaPLA General Hospital
Jun 17, 2023
Ebola Virus Disease, Marburg Virus Disease Trial in Oklahoma City (cAd3-Marburg, cAd3-EBO-S)
Completed
- Ebola Virus Disease
- Marburg Virus Disease
- cAd3-Marburg
- cAd3-EBO-S
-
Oklahoma City, OklahomaOklahoma Blood Institute (OBI)
Aug 2, 2022
Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)
Enrolling by invitation
- Malignant Melanomas
- Recombinant Human Adenovirus Type 5 Injection
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital, Department of Internal Medicine, Ward 19
Jul 7, 2023
Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)
Not yet recruiting
- Adenovirus
- +2 more
- Specific T- Lymphocytes
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Sep 8, 2023
Malignant Tumor Trial in Chengdu (Oncolytic Virus SDJ001, Oncolytic Virus YD06-1)
Recruiting
- Malignant Tumor
- Oncolytic Virus SDJ001
- Oncolytic Virus YD06-1
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 6, 2023
Lung Cancer Trial (TILT-123, Pembrolizumab)
Not yet recruiting
- Lung Cancer
- TILT-123
- Pembrolizumab
- (no location specified)
Nov 5, 2023
Healthy Trial in Worldwide (Ad26.Mos4.HIV, Clade C and Mosaic gp140 HIV bivalent vaccine, Placebo)
Active, not recruiting
- Healthy
- Ad26.Mos4.HIV
- +2 more
-
Birmingham, Alabama
- +52 more
Jan 17, 2023
Leukemia, Myeloid, Acute, MDS Trial in Wurzburg (TCM allogeneic humane central memory T cells, cryopreserved)
Completed
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- TCM allogeneic humane central memory T cells, cryopreserved
-
Wurzburg, GermanyUniversity Hospital Wuerzburg - Department of Medicine II
Jul 12, 2022
Norovirus Infections Trial in Cypress (VXA-G1.1-NN, Placebo Tablets, Norovirus GI.1 Norwalk Virus Inoculum)
Recruiting
- Norovirus Infections
- VXA-G1.1-NN
- +2 more
-
Cypress, CaliforniaAltaSciences LA
Apr 27, 2022
Bladder Cancer Trial in Hangzhou (H101, Camrelizumab)
Recruiting
- Bladder Cancer
- H101, Camrelizumab
-
Hangzhou, Zhejiang, ChinaHua Wang
Oct 2, 2022